This study is a single dose comfort comparison of Travoprost Bak Free 0.004% in one eye versus Latanoprost 0.005% in the opposite eye in patients with Primary Open-Angle Glaucoma or Ocular...
Date First Received: September 10, 2007
Last Updated: April 21, 2008
Verified by: Alcon Research, April 2008
Clinical Trial Phase: Phase 4 | Start Date: May 2007
Overall Status: Recruiting
Estimated Enrollment: 100
Brief Summary
Official Title: “A Single Dose Comfort Comparison of Travoprost Bak Free 0.004% in One Eye Versus Latanoprost 0.005% in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension”
Condition Keyword(s):
Intervention(s):
This study is a single dose comfort comparison of Travoprost Bak Free 0.004% in one eye versus Latanoprost 0.005% in the opposite eye in patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Dose Comparison, Parallel Assignment
Intervention(s) in this Clinical Trial
- Drug: Travoprost
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Have a clinical diagnosis of ocular hypertension, primary open-angel, exfoliation or pigment dispersion glaucoma in both eyes; visual acuity should be 20/100 or better in both eyes.
Exclusion Criteria:
- Age related
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Alcon Research
Overall Clinical Trial Officials and Contacts
Mark Jasek, PhD Study Director Alcon Research
Overall Contact: Cindy Garvin 843-762-6500
Additional Information
Information obtained from ClinicalTrials.gov on January 08, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00527592
Study ID Number: SMA-07-01
ClinicalTrials.gov Identifier: NCT00527592
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
